Skip to main content
. 2023 May 31:1–10. Online ahead of print. doi: 10.1007/s12603-023-1928-7

Table 3.

Unadjusted and Adjusted Quantile Regression Models of Median Change in Plasma Biomarkers

Biomarker Group Baseline Median (IQR)# Unadjusted Adjusted+
Coefficient (95% CI) p-value Coefficient (95% CI) p-value
IL6 (pg./mL) Control 3.20 (1.50) Reference
Exercise 2.65 (2.10) −0.20 (−1.63 – 1.23) p = 0.780 0.67 (−0.79 – 2.13) p = 0.360
Exercise + CST 3.10 (2.30) −0.10 (−1.33 – 1.13) p = 0.871 0.32 (−0.91 – 1.54) p = 0.602
IL10 (ng/mL) Control 2.39 (1.91) Reference
Exercise 2.25 (1.48) 0.31 (−0.50 – 1.12) p = 0.446 0.24 (−0.54 – 1.02) p = 0.543
Exercise + CST 2.61 (1.57) 0.53 (−0.17 – 1.23) p = 0.136 0.30 (−0.39 – 0.99) p = 0.385
TNF-α (pg./mL) Control 7.80 (3.80) Reference
Exercise 7.40 (2.90) −2.70 (−4.16 – −1.24) p <0.001 −2.71 (−4.80 – −0.62) p = 0.012
Exercise + CST 8.90 (3.80) −0.70 (−1.93 – 0.53) p = 0.257 −1.74 (−3.43 – −0.06) p = 0.043
GDF-15 (pg./mL) Control 943.15 (1083.90) Reference
Exercise 907.60 (786.70) 333.70 (−394.09 – 1061.49) p = 0.362 129.29 (−361.58 – 620.17) p = 0.597
Exercise + CST 943.30 (933.40) −35.70 (−662.52 – 591.52) p = 0.909 −164.61 (−583.09 – 253.87) p = 0.431

# No baseline differences were observed. + Adjusted for Age, Gender, Ethnicity, Education, Hypertension, Hyperlipidemia, Diabetes, Physical Activity, Polypharmacy, Cognition, IADL Impairment, Falls, Adherence and baseline values; IL-6, Interleukin 6; IL10, Interleukin 10E; TNF-α, Tumour Necrosis Factor-α; GDF-15, Growth Differentiation Factor-15.